Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Human neurotropic polyomavirus, JCV, and its role in carcinogenesis

Abstract

A number of recent studies have reported the detection of the ubiquitous human polyomavirus, JC virus (JCV), in samples derived from several types of neural as well as non-neural human tumors. The human neurotropic JCV was first identified as the etiologic agent of the fatal demyelinating disease, progressive multifocal leukoencephalopathy, which usually occurs in individuals with defects in cell-mediated immunity, including AIDS. However, upon mounting evidence of the oncogenic potential of the viral regulatory protein, T-antigen, and JCV's oncogenecity in a broad range of animal models, studies were initiated to determine its potential involvement in human carcinogenesis. Initially, the most frequently observed tumors in rodent models, including medulloblastoma, astrocytoma, glioblastoma, and other neural-origin tumors were analysed. These studies were followed by analysis of non-neural tumors such as colorectal carcinomas. In a subset of each tumor type examined, JC viral genomic DNA sequences could be detected by PCR and confirmed by Southern blot hybridization or direct sequencing. In a smaller subset of the tumors, the expression of T-antigen was observed by immunohistochemical analysis. Owing to the established functions of T-antigen including its ability to interact with tumor suppressor proteins such as Rb and p53, and its ability to influence chromosomal stability, potential mechanisms of JCV T-antigen-mediated cellular dysregulation are discussed. Further, as increasing evidence suggests that T-antigen is not required for maintenance of a transformed phenotype, a hit-and-run model for T-antigen-induced transformation is proposed.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Akatani K, Imai M, Kimura M, Nagashima K and Ikegami N . (1994). J. Med. Virol., 43, 13–19.

  • Arrington AS and Butel JS . (2001). Human Polyomaviruses: Molecular and Clinical Perspectives, Khalili K, Stoner GL (eds). Wiley-Liss: New York, NY.

    Google Scholar 

  • Assouline JG and Major EO . (1991). J. Virol., 65, 1002–1006.

  • Atwood WJ, Amemiya K, Traub R, Harms J and Major EO . (1992). Virology, 190, 716–723.

  • Baron-Van Evercooren A, Jensen NA, Wyss MT, Cuzin F, Rassoulzadegan M, Brucher JM and Baron H . (1992). Lab. Invest., 66, 39–53.

  • Berger JR and Concha M . (1995). J. Neurovirol., 1, 5–18.

  • Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, Calafell F and Girones R . (2001). J. Virol., 75, 10290–10299.

  • Boldorini R, Caldarelli-Stefano R, Monga G, Zocchi M, Mediati M, Tosoni A and Ferrante P . (1998). J. Neurovirol., 2, 242–245.

  • Bollag B, Chuke WF and Frisque RJ . (1989). J. Virol., 63, 863–872.

  • Brun A and Jonsson N . (1984). Cancer, 53, 1714–1717.

  • Caldarelli-Stefano R, Boldorini R, Monga G, Meraviglia E, Zorini EO and Ferrante P . (2000). Hum. Pathol., 3, 394–395.

  • Castaigne P, Rondot P, Escourolle R, Ribadeau Dumas J-L, Cathala F and Hauw J-J . (1974). Rev. Neurol. (Paris), 130, 379–392.

  • Corallini A, Tognon M, Negrini M and Barbanti-Brodano G . (2001). Human Polyomaviruses: Molecular and Clinical Perspectives, Khalili K, Stoner GJ (eds).. Wiley-Liss: New York, NY.

    Google Scholar 

  • Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A and Khalili K . (2002). Oncogene, 21, 5574–5581.

  • Del Valle L, Delbue S, Gordon J, Enam S, Croul S, Ferrante P and Khalili K . (2002b). Neurology, 58, 895–900.

  • Del Valle L, Enam S, Lara C, Ortiz-Hidalgo C, Katsetos CD and Khalili K . (2002c). Clin. Cancer Res., 8, 3332–3340.

  • Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis J, Katsetos CD, Croul S and Khalili K . (2001). Cancer Res., 61, 4287–4293.

  • Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakoupoulou M, Katsetos CD and Khalili K . (2002a). J. Natl. Cancer Inst., 94, 267–273.

  • Del Valle L, Wang JY, Lassak A, Peruzzi F, Croul S, Khalili K and Reiss K . (2002d). J. Neurovirol., (Suppl. 2) 8, 138–147

  • De Mattei M, Martini F, Corallini A, Gerosa M, Scotlandi K, Carinci P, Barbanti-Brodano G and Tognon M . (1995). Int. J. Cancer, 61, 756–760.

  • Devireddy LR, Kuman KU, Pater MM and Pater A . (1996). J. Med. Virol., 49, 205–211.

  • Dyson N, Bernards R, Friend SH, Gooding LR, Hassel JA, Major EO, Pipas JM, Van Dyke T and Harlow E . (1990). J. Virol., 64, 1353–1356.

  • Dyson N, Buchkovich K, Whyte P and Harlow E . (1989). Cell, 58, 249–255.

  • Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP and Khalili K . (2002). Cancer Res., 62, 7093–7101.

  • Franks RR, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL and Khalili K . (1996). Oncogene, 12, 2573–2578.

  • Frisque RJ, Bream GL and Cannella MT . (1984). J. Virol., 51, 458–469.

  • Frye S, Trebst C, Dittmer U, Petry H, Bodemer M, Hunsmann G, Weber T and Luke W . (1997). J. Virol. Methods, 63, 81–92.

  • Gan DD, Reiss K, Gorrill T, Del Valle L, Croul S, Giordano A, Fishman P and Khalili K . (2001). Oncogene, 20, 4864–4870.

  • Gordon J, Del Valle L, Otte J and Khalili K . (2000). Oncogene, 19, 4840–4846.

  • Haas S, Haque NS, Beggs AH, Khalili K, Knobler RL and Small J . (1994). Virology, 202, 89–96.

  • Haggerty S, Walker DL and Frisque RJ . (1989). J. Virol., 63, 2180–2190.

  • Hara K, Sugimoto C, Kitamura T, Aoki N, Taguichi F and Yogo Y . (1998). J. Virol., 72, 5335–5342.

  • Kitamura T, Kunitkake T, Guo J, Tominaga T, Kawabe K and Yogo Y . (1994). J. Clin. Microbiol., 32, 2359–2363.

  • Krynska B, Del Valle L, Gordon J, Otte J, Croul S and Khalili K . (2000). Virology, 274, 65–74.

  • Krynska B, Del Valle L, Croul S, Gordon J, Katsetos K, Carbone M, Giordano A and Khalili K . (1999a). Proc. Natl. Acad. Sci. USA, 96, 11 519–11 524.

  • Krynska B, Otte J, Franks R, Khalili K and Croul S . (1999b). Oncogene, 18, 39–46.

  • Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV and Boland CR . (1999). Proc. Natl. Acad. Sci. USA, 96, 7484–7489.

  • Lazutka JR, Neel JV, Major EO, Dedonyte V, Mierauskine J, Slapsyte G and Kesminieni A . (1996). Cancer Lett., 109, 177–183.

  • Leon SP, Zhu L and Black P McL . (1994). Neurosurgery, 34, 708–722.

  • London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM and Ohashi T . (1978). Science, 201, 1246–1249.

  • Ludlow JW and Skuse GR . (1995). Virus Res., 35, 113–121.

  • Lynch KJ, Haggerty S and Frisque RJ . (1994). Virology, 204, 819–822.

  • Major EO, Amemiya K, Tornatore CS, Houff SA and Berger JR . (1992). Clin. Microbiol. Rev., 5, 49–73.

  • Major EO, Miller AI, Mourrain P, Traub RG, De Widt E and Sever J . (1985). Proc. Natl. Acad. Sci. USA, 82, 1257–1261.

  • Major EO and Vacante DA . (1989). J. Neuropathol. Exp. Neurol., 48, 425–436.

  • Major EO, Vacante DA, Traub RG, London WT and Sever JL . (1987). J Virol., 61, 1435–1441.

  • Mandl C, Walker DL and Frisque RJ . (1987). J. Virol., 61, 755–763.

  • Matsuda M, Yasui K, Nagashima K and Mori W . (1987). J. Natl. Cancer Inst., 79, 585–591.

  • Molenaar WM and Trojanowski JQ . (1994). Crit. Rev. Oncol. Hematol., 17, 1–25.

  • Monaco MCG, Jensen PN, Hou J, Durham LC and Major EO . (1998). J. Virol., 9918–9923.

  • Nagashima K, Yasui K, Kimura J, Washizu M, Yamaguchi K and Mori W . (1984). Am. J. Pathol., 116, 455–463.

  • Neel JV, Major EO, Awa AA, Glover T, Burgess A, Troub R, Curfman B and Satoh C . (1996). Proc. Natl. Acad. Sci. USA, 93, 2690–2695.

  • Ohsumi S, Motoi M and Ogawa K . (1986). Acta. Pathol. Jpn., 36, 815–825.

  • Padgett BL and Walker DL . (1973). J. Infect. Dis., 127, 467–470.

  • Price RW . (1996). Lancet, 348, 445–452.

  • Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K and Andrews D . (1996). Proc. Natl. Acad. Sci. USA, 93, 7352–7357.

  • Riccardiello L, Chang DK, Laghi L, Goel A, Chang CL and Boland R . (2001). J. Virol., 75, 1996–2001.

  • Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE and Boland CR . (2000). Gastroenterology, 119, 1228–1235.

  • Richardson EP . (1961). New Engl. J. Med., 265, 815–823.

  • Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K and Khalili K . (2001). J Virol, 75, 1476–1486.

  • Shinohara T, Nagashima K and Major EO . (1997). Virology, 2, 269–277.

  • Sima AAF, Finkelstein SD and MacLachlan DR . (1983). Ann. Neurol., 14, 183–188.

  • Small JA, Scangos GA, Cork L, Jay G and Khoury G . (1986a). Cell, 46, 13–18.

  • Small JA, Khoury G, Jay G, Howley PM and Scangos GA . (1986b). Proc. Natl. Acad. Sci. USA, 83, 8288–8292.

  • Theile M and Grabowski G . (1990). Arch. Virol., 113, 221–233.

  • Vacante DA, Traub R and Major EO . (1989). Virology, 170, 353–361.

  • Walker DL and Padgett BL . (1983). Prog. Clin. Biol. Res., 105, 99–106.

  • Walker DL, Padgett BL, Zu Rhein GM, Albert AE and Marsh RF . (1973). Science, 181, 674–676.

  • Woodruff JM, Kourea HP, Louis DN and Scheithauer BW . (2000). Pathology and Genetics of Tumors of the Nervous System, Kleihues P, Cavenee WK (eds.). IARC Press: Lyon, France.

    Google Scholar 

  • Wroblewska Z, Wellish M and Gilden D . (1980). Arch. Virol., 65, 141–148.

  • Zu Rhein GM . (1983). Polyomaviruses and Human Neurological Diseases. Alan R. Liss, Inc.: New York, NY, pp. 205–221.

    Google Scholar 

  • Zu Rhein GM and Varakis JN . (1979). Natl. Cancer Inst. Monogr., 51, 205–208.

Download references

Acknowledgements

We thank past and present members of the Center for Neurovirology and Cancer Biology for their insightful discussion, and sharing of ideas of reagents. We also thank C Schriver for preparation of this manuscript. This work was made possible by grants awarded by NIH to JG and KK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kamel Khalili.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khalili, K., Del Valle, L., Otte, J. et al. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 22, 5181–5191 (2003). https://doi.org/10.1038/sj.onc.1206559

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206559

Keywords

This article is cited by

Search

Quick links